Axcynsis Therapeutics
Manufacturing · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
41 Science Park Rd, Singapore, Central S...Website
www.axcynsis.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Axcynsis Therapeutics
Axcynsis Therapeutics is a biotechnology company dedicated to developing Antibody-X Conjugate (AXC) therapies aimed at transforming cancer treatment. Utilizing proprietary technologies, the company is building a strong pipeline of AXC candidates to meet unmet medical needs for innovative treatment options. Their focus is on addressing significant challenges in cancer therapy through advanced biotechnological solutions. Axcynsis Therapeutics serves clients in the healthcare sector, particularly those involved in cancer treatment and research.Explore more
Axcynsis Therapeutics Org Chart
MA
Vice President, Clinical Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Axcynsis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Axcynsis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Axcynsis Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Axcynsis Therapeutics
Funding: Get notified immidiatlly once Axcynsis Therapeutics has new funding data
Product Launch: Get notified when Axcynsis Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Axcynsis Therapeutics had a recent Job posting/layoffs
Axcynsis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Axcynsis Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Axcynsis Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Axcynsis Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Axcynsis Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Axcynsis Therapeutics.
Axcynsis Therapeutics Tech Stack
A closer look at the technologies used by Axcynsis Therapeutics
See more technologies
Most Recent Scoops
Open Position
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Project
Research & Development, Compliance, Legal Affairs, Medical Research, Pharmaceuticals
Open Position
Axcynsis Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Axcynsis Therapeutics
Sign Up For FreeTo access detailed company insights
Axcynsis Therapeutics is a biotechnology company dedicated to developing Antibody-X Conjugate (AXC) therapies aimed at transforming cancer treatment. Utilizing proprietary technologies, the company is building a strong pipeline of AXC candidates to meet unmet medical needs for innovative treatment options. Their focus is on addressing significant c... Read More
